Colinz Labs declares non-applicability of related party disclosures
- Colinz Laboratories Limited declared non-applicability of Related Party Transaction disclosures for Q2FY27
- Company cited exemption under Regulation 15(2)(a) of SEBI (LODR) Regulations, 2015
- Compliance with Regulations 17 to 27 and specific clauses of Regulation 46 is not applicable
- Filing signed by Director Vijaya Mani on October 1, 2026

*this image is generated using AI for illustrative purposes only.
Colinz Laboratories Limited has informed the Bombay Stock Exchange that it is not required to submit Related Party Transaction (RPT) disclosures for the quarter ended September 30, 2026. The company invoked an exemption under SEBI regulations to bypass this specific compliance requirement.
The declaration was made pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company stated that compliance with provisions specified in Regulations 17 to 27 and clauses (b) to (i) [and (t)] of sub-regulation (2) of Regulation 46, along with para C, D, and E of Schedule V, shall not apply.
Regulatory Basis for Exemption
The company claimed exemption under Regulation 15(2)(a) of the SEBI (LODR) Regulations, 2015. This regulation allows certain entities to be exempt from specific governance and disclosure norms if they meet defined criteria, such as being a subsidiary or having a specific shareholder structure. Consequently, the mandatory submission of RPT details for the second quarter of fiscal year 2027 is waived.
Key Filing Details
| Detail | Information |
|---|---|
| Quarter Ended | September 30, 2026 |
| Regulation Cited | Regulation 23(9), SEBI LODR |
| Exemption Clause | Regulation 15(2)(a), SEBI LODR |
| Signatory | Vijaya Mani, Director |
The filing was digitally signed by Vijaya Mani, Director of the company, on October 1, 2026. The communication was addressed to the BSE at Phiroze Jeejeebhoy Towers, Mumbai. No financial performance metrics or operational updates were disclosed in this specific regulatory filing.
Historical Stock Returns for Colinz Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -4.16% | -0.54% | -0.68% | +65.17% | +77.97% | +276.92% |
How might the reliance on Regulation 15(2)(a) exemptions impact investor confidence in Colinz Laboratories' corporate governance transparency compared to peers?
Will SEBI introduce stricter scrutiny or regulatory changes targeting companies that frequently utilize governance exemptions to bypass RPT disclosures?
What specific shareholder structure criteria is Colinz Laboratories leveraging to maintain its eligibility for the Regulation 15(2)(a) exemption in future quarters?

































